Vaccination

Researchers presented data at IDWeek showing that socioeconomic vulnerability and race can negatively impact vaccine uptake.

BOSTON — Vaccine hesitancy was less likely to occur in racially diverse vs. white patients, although this hesitancy was not significantly impacted by age, sex or language, according to a poster presentation here.

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

More than half of children with acute otitis media and 32% of children with upper respiratory infections tested positive for multiple pathogens in their nasal passages, according to a study presented at IDWeek.

There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vaccine requirement in mid-2023.

LOS ANGELES — Neutralizing antibodies against mpox generated by the Jynneos vaccine were short lived — lasting less than a year — if patients had never received a smallpox vaccine as children, researchers said.

A healthy, 10-year-old boy seeks care for a sore left cheek.

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

LOS ANGELES — Paxlovid reduced the risk for severe COVID-19 hospitalization or death among people with existing immunity from a previous infection or vaccination, according to pooled trial data presented at IDWeek.